BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

500 related articles for article (PubMed ID: 11709310)

  • 1. Functional expression of Candida albicans drug efflux pump Cdr1p in a Saccharomyces cerevisiae strain deficient in membrane transporters.
    Nakamura K; Niimi M; Niimi K; Holmes AR; Yates JE; Decottignies A; Monk BC; Goffeau A; Cannon RD
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3366-74. PubMed ID: 11709310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulated overexpression of CDR1 in Candida albicans confers multidrug resistance.
    Niimi M; Niimi K; Takano Y; Holmes AR; Fischer FJ; Uehara Y; Cannon RD
    J Antimicrob Chemother; 2004 Dec; 54(6):999-1006. PubMed ID: 15486081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters.
    Sanglard D; Kuchler K; Ischer F; Pagani JL; Monod M; Bille J
    Antimicrob Agents Chemother; 1995 Nov; 39(11):2378-86. PubMed ID: 8585712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ABC transporter Cdr1p contributes more than Cdr2p does to fluconazole efflux in fluconazole-resistant Candida albicans clinical isolates.
    Holmes AR; Lin YH; Niimi K; Lamping E; Keniya M; Niimi M; Tanabe K; Monk BC; Cannon RD
    Antimicrob Agents Chemother; 2008 Nov; 52(11):3851-62. PubMed ID: 18710914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positive regulation of the Candida albicans multidrug efflux pump Cdr1p function by phosphorylation of its N-terminal extension.
    Tsao S; Weber S; Cameron C; Nehme D; Ahmadzadeh E; Raymond M
    J Antimicrob Chemother; 2016 Nov; 71(11):3125-3134. PubMed ID: 27402010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Candida albicans zinc cluster protein Upc2p confers resistance to antifungal drugs and is an activator of ergosterol biosynthetic genes.
    MacPherson S; Akache B; Weber S; De Deken X; Raymond M; Turcotte B
    Antimicrob Agents Chemother; 2005 May; 49(5):1745-52. PubMed ID: 15855491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substrates and modulators of the multidrug transporter Cdr1p of Candida albicans in antifungal extracts of medicinal plants.
    Kolaczkowski M; Kolaczkowska A; Sroda K; Ramalhete C; Michalak K; Mulhovo S; Ferreira MJ
    Mycoses; 2010 Jul; 53(4):305-10. PubMed ID: 19460101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lathyrol and epoxylathyrol derivatives: Modulation of Cdr1p and Mdr1p drug-efflux transporters of Candida albicans in Saccharomyces cerevisiae model.
    Mónico A; Nim S; Duarte N; Rawal MK; Prasad R; Di Pietro A; Ferreira MU
    Bioorg Med Chem; 2017 Jul; 25(13):3278-3284. PubMed ID: 28479022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The monoamine oxidase A inhibitor clorgyline is a broad-spectrum inhibitor of fungal ABC and MFS transporter efflux pump activities which reverses the azole resistance of Candida albicans and Candida glabrata clinical isolates.
    Holmes AR; Keniya MV; Ivnitski-Steele I; Monk BC; Lamping E; Sklar LA; Cannon RD
    Antimicrob Agents Chemother; 2012 Mar; 56(3):1508-15. PubMed ID: 22203607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ABC multidrug transporter Cdr1p of Candida albicans has divergent nucleotide-binding domains which display functional asymmetry.
    Jha S; Dabas N; Karnani N; Saini P; Prasad R
    FEMS Yeast Res; 2004 Oct; 5(1):63-72. PubMed ID: 15381123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Candida glabrata ATP-binding cassette transporters Cdr1p and Pdh1p expressed in a Saccharomyces cerevisiae strain deficient in membrane transporters show phosphorylation-dependent pumping properties.
    Wada S; Niimi M; Niimi K; Holmes AR; Monk BC; Cannon RD; Uehara Y
    J Biol Chem; 2002 Nov; 277(48):46809-21. PubMed ID: 12244114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ATP binding cassette transporter gene CgCDR1 from Candida glabrata is involved in the resistance of clinical isolates to azole antifungal agents.
    Sanglard D; Ischer F; Calabrese D; Majcherczyk PA; Bille J
    Antimicrob Agents Chemother; 1999 Nov; 43(11):2753-65. PubMed ID: 10543759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal of antifungal resistance mediated by ABC efflux pumps from Candida albicans functionally expressed in yeast.
    Schuetzer-Muehlbauer M; Willinger B; Egner R; Ecker G; Kuchler K
    Int J Antimicrob Agents; 2003 Sep; 22(3):291-300. PubMed ID: 13678837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Divergent functions of three Candida albicans zinc-cluster transcription factors (CTA4, ASG1 and CTF1) complementing pleiotropic drug resistance in Saccharomyces cerevisiae.
    Coste AT; Ramsdale M; Ischer F; Sanglard D
    Microbiology (Reading); 2008 May; 154(Pt 5):1491-1501. PubMed ID: 18451058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substitution of threonine-1351 in the multidrug transporter Cdr1p of Candida albicans results in hypersusceptibility to antifungal agents and threonine-1351 is essential for synergic effects of calcineurin inhibitor FK520.
    Shukla S; Ambudkar SV; Prasad R
    J Antimicrob Chemother; 2004 Jul; 54(1):38-45. PubMed ID: 15190023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curcumin potentiates the fungicidal effect of dodecanol by inhibiting drug efflux in wild-type budding yeast.
    Yamawaki C; Oyama M; Yamaguchi Y; Ogita A; Tanaka T; Fujita KI
    Lett Appl Microbiol; 2019 Jan; 68(1):17-23. PubMed ID: 30276838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional analysis of fungal drug efflux transporters by heterologous expression in Saccharomyces cerevisiae.
    Niimi M; Wada S; Tanabe K; Kaneko A; Takano Y; Umeyama T; Hanaoka N; Uehara Y; Lamping E; Niimi K; Tsao S; Holmes AR; Monk BC; Cannon RD
    Jpn J Infect Dis; 2005 Feb; 58(1):1-7. PubMed ID: 15728981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemosensitization of fluconazole resistance in Saccharomyces cerevisiae and pathogenic fungi by a D-octapeptide derivative.
    Niimi K; Harding DR; Parshot R; King A; Lun DJ; Decottignies A; Niimi M; Lin S; Cannon RD; Goffeau A; Monk BC
    Antimicrob Agents Chemother; 2004 Apr; 48(4):1256-71. PubMed ID: 15047528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum repressing efflux pump CDR1 in Candida albicans.
    Yang YL; Lin YH; Tsao MY; Chen CG; Shih HI; Fan JC; Wang JS; Lo HJ
    BMC Mol Biol; 2006 Jul; 7():22. PubMed ID: 16839415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of fluconazole resistance in Candida albicans isolates from Japanese AIDS patients.
    Maebashi K; Niimi M; Kudoh M; Fischer FJ; Makimura K; Niimi K; Piper RJ; Uchida K; Arisawa M; Cannon RD; Yamaguchi H
    J Antimicrob Chemother; 2001 May; 47(5):527-36. PubMed ID: 11328762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.